Signals
Desmoid Tumours Are Not Benign to the People Living With Them
FDA has accepted Immunome’s NDA for varegacestat in adults with progressing desmoid tumours. The label may say non-metastatic. The burden can still be brutal.
Sleep is now cardiovascular prevention. Health systems still treat it like lifestyle advice
The GLP-1 boom still needs exercise policy
ADHD Does Not Stop Being ADHD When Anxiety Walks Into the Room
Pharmacists are becoming the front door for cardiometabolic care. Policy is still treating them like the back office
Dementia prevention has a cardiometabolic blind spot
The Money Is Moving Into Cancer Screening. The Evidence Still Has to Catch Up.
Huntington’s Needs More Than a Better Curve
New nicotine products could become the next major cardiovascular policy failure
Childhood obesity is the next cardiometabolic crisis already unfolding
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.